AAA June 2015 – Page 3

Seres to enter public life with $134m IPO

Seres Therapeutics, a US-based bacterial infection treatment developer backed by food and nutrition product maker Nestlé and health researcher Mayo Clinic, priced its $134m initial public offering yesterday. The company is issuing more than 7.4 million shares priced at $18 each, above the $15 to $17 range it set last week. It will begin trading… Continue reading Seres to enter public life with $134m IPO

Quadrille raises $73m for AG2R-LA Mondial-fund

France-based venture capital and private equity firm Quadrille Capital reached the €65 ($72.9m) first close of its first fund yesterday after securing capital from backers including insurance and financial services group AG2R-La Mondiale. The fund’s limited partners also include French state-owned investment bank BPIfrance, Dutch state-owned bank ABN Amro, insurance firm Prévoir Group and undisclosed… Continue reading Quadrille raises $73m for AG2R-LA Mondial-fund